Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...
Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to ...
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...
Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...
The global satellite-based earth observation market size is estimated to grow by USD 9.66 billion from 2025 to 2029, ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of ...
Report on how AI is redefining market landscape - The global non-fungible token (NFT) market size is estimated to grow by ...
General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, "Toripalimab has made significant strides in its ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Shanghai Junshi Biosciences Co., Ltd. announced that its investigational new drug application for JS212 injection has been accepted by the National Medical Products Administration. JS212 is a ...
Madrid, Jan 8 (EFE).- Spanish Prime Minister Pedro Sánchez and his cabinet will preside over the opening of a series of activities to commemorate the 50th death anniversary of dictator Francisco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback